178 related articles for article (PubMed ID: 28967561)
1. The validity of Acuros BV and TG-43 for high-dose-rate brachytherapy superficial mold treatments.
Boman EL; Satherley TWS; Schleich N; Paterson DB; Greig L; Louwe RJW
Brachytherapy; 2017; 16(6):1280-1288. PubMed ID: 28967561
[TBL] [Abstract][Full Text] [Related]
2. Dose comparison between TG-43-based calculations and radiochromic film measurements of the Freiburg flap applicator used for high-dose-rate brachytherapy treatments of skin lesions.
Aldelaijan S; Bekerat H; Buzurovic I; Devlin P; DeBlois F; Seuntjens J; Devic S
Brachytherapy; 2017; 16(5):1065-1072. PubMed ID: 28735877
[TBL] [Abstract][Full Text] [Related]
3. Limitations of the TG-43 formalism for skin high-dose-rate brachytherapy dose calculations.
Granero D; Perez-Calatayud J; Vijande J; Ballester F; Rivard MJ
Med Phys; 2014 Feb; 41(2):021703. PubMed ID: 24506594
[TBL] [Abstract][Full Text] [Related]
4. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
[TBL] [Abstract][Full Text] [Related]
5. Experimental assessment of the Advanced Collapsed-cone Engine for scalp brachytherapy treatments.
Cawston-Grant B; Morrison H; Sloboda RS; Menon G
Brachytherapy; 2018; 17(2):489-499. PubMed ID: 29239813
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry comparison between TG-43 and Monte Carlo calculations using the Freiburg flap for skin high-dose-rate brachytherapy.
Vijande J; Ballester F; Ouhib Z; Granero D; Pujades-Claumarchirant MC; Perez-Calatayud J
Brachytherapy; 2012; 11(6):528-35. PubMed ID: 22226080
[TBL] [Abstract][Full Text] [Related]
7. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
Poon E; Verhaegen F
Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
[TBL] [Abstract][Full Text] [Related]
8. Development of a phantom to validate high-dose-rate brachytherapy treatment planning systems with heterogeneous algorithms.
Moura ES; Micka JA; Hammer CG; Culberson WS; DeWerd LA; Rostelato ME; Zeituni CA
Med Phys; 2015 Apr; 42(4):1566-74. PubMed ID: 25832047
[TBL] [Abstract][Full Text] [Related]
9. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate
Ma Y; Vijande J; Ballester F; Tedgren ÅC; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith R; Chamberland MJP; Thomson RM; Verhaegen F; Beaulieu L
Med Phys; 2017 Nov; 44(11):5961-5976. PubMed ID: 28722180
[TBL] [Abstract][Full Text] [Related]
10. Varian HDR surface applicators - commissioning and clinical implementation.
Iftimia I; McKee AB; Halvorsen PH
J Appl Clin Med Phys; 2016 Mar; 17(2):231-248. PubMed ID: 27074486
[TBL] [Abstract][Full Text] [Related]
11. Monte Carlo dose calculations for high-dose-rate brachytherapy using GPU-accelerated processing.
Tian Z; Zhang M; Hrycushko B; Albuquerque K; Jiang SB; Jia X
Brachytherapy; 2016; 15(3):387-398. PubMed ID: 27216118
[TBL] [Abstract][Full Text] [Related]
12. RapidBrachyTG43: A Geant4-based TG-43 parameter and dose calculation module for brachytherapy dosimetry.
Kalinowski J; Enger SA
Med Phys; 2024 May; 51(5):3746-3757. PubMed ID: 38252746
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of a 2D diode array in "magic phantom" for use in high dose rate brachytherapy pretreatment quality assurance.
Espinoza A; Petasecca M; Fuduli I; Howie A; Bucci J; Corde S; Jackson M; Lerch ML; Rosenfeld AB
Med Phys; 2015 Feb; 42(2):663-673. PubMed ID: 28102606
[TBL] [Abstract][Full Text] [Related]
14. A BrachyPhantom for verification of dose calculation of HDR brachytherapy planning system.
Austerlitz C; Campos CA
Med Phys; 2013 Nov; 40(11):112103. PubMed ID: 24320456
[TBL] [Abstract][Full Text] [Related]
15. HDR brachytherapy with surface applicators: technical considerations and dosimetry.
Sabbas AM; Kulidzhanov FG; Presser J; Hayes MK; Nori D
Technol Cancer Res Treat; 2004 Jun; 3(3):259-67. PubMed ID: 15161319
[TBL] [Abstract][Full Text] [Related]
16. Phantom size in brachytherapy source dosimetric studies.
Pérez-Calatayud J; Granero D; Ballester F
Med Phys; 2004 Jul; 31(7):2075-81. PubMed ID: 15305460
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric accuracy of a deterministic radiation transport based (192)Ir brachytherapy treatment planning system. Part III. Comparison to Monte Carlo simulation in voxelized anatomical computational models.
Zourari K; Pantelis E; Moutsatsos A; Sakelliou L; Georgiou E; Karaiskos P; Papagiannis P
Med Phys; 2013 Jan; 40(1):011712. PubMed ID: 23298082
[TBL] [Abstract][Full Text] [Related]
18. Comparison of TG-43 and TG-186 in breast irradiation using a low energy electronic brachytherapy source.
White SA; Landry G; Fonseca GP; Holt R; Rusch T; Beaulieu L; Verhaegen F; Reniers B
Med Phys; 2014 Jun; 41(6):061701. PubMed ID: 24877796
[TBL] [Abstract][Full Text] [Related]
19. Validation of GPUMCD for low-energy brachytherapy seed dosimetry.
Hissoiny S; Ozell B; Després P; Carrier JF
Med Phys; 2011 Jul; 38(7):4101-7. PubMed ID: 21859010
[TBL] [Abstract][Full Text] [Related]
20. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
